SlideShare a Scribd company logo
Dr. T. Citarasu
Associate Professor
Tele-fax: + 91-4652-253078
Mobile: +91-9994273822
Email: citarasu@gmail.com
citarasu@msuniv.ac.in
Website: www.msuniv.ac.in
www.msuniv.irins.org/profile/174278
CENTRE FOR MARINE SCIENCE AND TECHNOLOGY
MANONMANIAM SUNDARANAR UNIVERSITY, TIRUNELVELI
AQUACULTURE VACCINE
DEVELOPMENT
Chemotherapy and antibiotics are giving
positive effects for treating disease, there
are some drawbacks, such as residual
problem, resistance strain development,
bio magnification and host immune
system suppression etc.
Considering the potential threats of
diseases on one side and environmental
issues on the other side, attention should
be focused to developing alternative
practices for solving problems such as
vaccine and immunostimulants.
Development of immunostimulation and
vaccines with advanced protocols are
effective to boost the immune system
against bacterial, viral and parasitic
diseases.
NEED OF VACCINES
THE CRUCIAL TRAITS OF AQUACULTURE VACCINES
Induce long-lasting protective immune
memory and preventative immunity
Elicit humoral and cell - mediated
immunological responses in the host
B cells store the memory and trigger the
immunity when subsequent exposure of
pathogens
A vaccination is deemed safe if it
immunizes in a manner similar to a
natural infection but does not negative
side effects, and the fish vaccine must be
risk-free for the final consumer
Must be good protection, stress free and
time efficient with mass immunization
Equally effective in multiple fish species
and cost-effectiveness make profit
GENERATION OF VACCINES
FIRST GENERATION OF VACCINES
First-generation vaccinations are forms of
microbial pathogens like live, weakened,
and killed bacteria and viruses.
They do not trigger cell-mediated immune
responses; only humoral immune
responses are elicited.
Live-attenuated vaccines contain live
microorganisms that have been
"weakened" or rendered incapable of
causing disease but some occasions they
revert their virulence
Self-replicating qualities of live vaccines
they do not require booster dose
Genetic attenuation by mutation (deletion,
disruption of the metabolic pathway or
virulence gene); chemical (formaldehyde)
& physical (heat and UV radiation)
Contains defined protein antigens
or recombinant protein
components capable of inducing
humoral and cell mediated immune
responses, particularly T helper
antibody responses
Antigens are crude proteins
extracted and purified from
pathogens and also specific
immunogenic proteins can be
expressed and purified using
different recombinant expression
systems
Antigenic components are unable
to proliferate in the host and no
threat of pathogenicity to the host
SECOND GENERATION OF VACCINES
Examples of bacterial extra cellular
toxins like haemolysin, bacterial
outer membrane protein (OMP),
viral envelop protein etc.
They are incredibly safe method of
vaccination and are less side
effects.
They have the ability to elicit an
immune response and mount
immunological response and
memory.
Multiple doses of the subunit
vaccinations may be necessary,
and immunological adjuvant is
required for effective generation of
antibodies
THIRD GENERATION OF VACCINE
A short, circular piece of bacterial
DNA (plasmid) that has been
genetically modified to create one or
two specific proteins (antigens) from
a microorganism makes up DNA
vaccines, which are third-generation
vaccinations.
Host cells receive the vaccine DNA
and the "inner machinery" of the host
cells "reads" the DNA to produce
corresponding target proteins.
The host cells process them and
expose them on their surface, the
immune system is notified and
causes a variety of humoral and cell-
mediated powerful and long-lasting
immune responses to be triggered
CONVENTIONAL VACCINES AND THEIR DRAWBACKS
Unfortunately, they have several
drawbacks, such as a week or
shorter immunity, reversal of
virulence, ineffectiveness, heat
liability, etc.
The risk of new strains emerging
from recombination of various
strains in live attenuated vaccines
exists.
In order to retain an acceptable
degree of protective immunity for a
longer period of time and enhance
their efficiency, inactivated
vaccines require multiple booster
doses, proper adjuvant, etc.
Typically, inactivated vaccines are ineffective against
viral infections and intracellular microorganisms
Physical or chemical treatments that result in
denaturation of the proteins or damage to the nucleic
acids in inactivated and killed vaccines
Also toxoid vaccines mixed with immune adjuvant are
effective but high level bio safety is required
TYPES OF VACCINES
NON EXPRESSED VACCINES
Subunit Vaccines
The short, specialized proteins of a
pathogen that is non-infectious
because they cannot reproduce in
the host and promote strong
immunological response
By directly extracting the native
protein from pathogen cultures,
subunit vaccines can be made.
By include more than one protein
in a subunit vaccine; it is possible
to establish immunity against more
than one strain or serotype of a
bacterial or viral disease.
S/A-layer proteins, extracellular products
(ECP), outer membrane proteins (OMP),
synthetic peptides, & lipopolysachharides
(LPS) are common examples of subunit
proteins.
When administered by injection along
with an immunoadjuvant, they are more
efficient.
They have some drawbacks, such as the
need for immunoadjuvants and the need
for precise understanding of the epitope
structure of the protective antigens of the
pathogen for the vaccine.
Non expressed subunit vaccines have the
drawback of having a low level of
immunogenicity, requiring more doses
and immuno-adjuvants
BIOFILM VACCINE
Cells embedded in a matrix create
biofilms; structures that help
bacteria adapt to various micro
niches and endure harsh
environmental circumstances.
Bacterial cells within the biofilm and
those located in its matrix, which
includes polysaccharides,
extracellular proteins, and DNA, are
key sources of biofilm antigens.
The extracellular matrix, also known
as extracellular polymeric
substances, or EPS, which is made
up of proteins, lipids,
exopolysaccharides, and
extracellular DNA (eDNA), surrounds
the biofilm bacterium.
Biofilm antigens obtained from several bacterial pathogens
were highly influenced to boost the immune system in fish
species
Oral biofilm vaccines have been confirmed to have
protective effects for many fish, such as, Lates calcarifer,
Labeo rohita , Oreochromis sp., Cyprinus carpio, and Mugil
cephalus
The TLR 3, IL-1, and IL-8 genes were up-regulated in the
vaccinated fish 28 days after immunization, which increased
survival and immunological parameter
EGG YOLK EDIBLE VACCINE IgY
When chickens are faced with a foreign
virus or bacterium, they produce
antibodies to fight the invader. They pass
that immunity on to their offspring, and
antibodies wind up in the eggs.
1. Chickens are more apt than mammals
to make high-avidity antibodies
2. A single chicken can produce an
enormous amount of antibody, up to
3 grams of IgY per month, which is
10-20 times the amount of a rabbit
3. Chickens produce antibody much
quicker-high-titre antibody is
available from eggs as early as day 25
4. Storing of eggs (antibodies) is very
easy
APPLICATIONS AND ADVANTAGES
Research , diagnostics & therapy
High specificity to target antigens
Less cross reactivity compared with mammalian antibody
Potential therapeutic applications, such as passive
immunization
Effective against drug-resistant bacteria.
It is cheaper to feed and house chickens than rabbits
GENETICALLY ALTERED VACCINES
By deleting, disrupting, or altering the
metabolic pathway or virulence genes
that causes attenuation in pathogens
used as live-attenuated vaccinations.
This modification aids in turning a
pathogen into non-pathogenic and
produces a host's protective immune
response.
Attenuated live vaccines against
Streptococcus iniae, Vibrio
anguillarum, Flavobacterium
columnare, Edwardsiella ictaluri, A.
hydrophila and E. tarda.
Effective, but due to some of the
safety concerns, mostly not accepted
for aquaculture operations.
VECTORS EXPRESSED VACCINES
DNA VACCINE
The ability of DNA vaccines to trigger
both cellular and humoral immune
responses that provide meaningful
protection against fish diseases is
one of its numerous advantages over
conventional immunization
techniques.
Immunization with a circular piece of
DNA that code for an antigen
Plasmids consist of strong viral
promoter (SV-40/CMV ) to drive the in
vivo transcription and translation of
gene interest.
Intron A may sometimes be included to improve mRNA
stability and hence increase protein expression.
Plasmids also include a strong polyadenylation/transcriptional
termination signal, such as bovine growth hormone or rabbit
beta-globulin polyadenylation sequences.
Multi-cistronic vectors are sometimes constructed to express
more than one immunogen, or to express an immunogen and
an immunostimulatory protein
Recombinant plasmids enter to the host cell
Gene of interest is transcribed by the RNA polymerase II & synthesis
of messenger RNA (mRNA)
Translated into the corresponding protein in the cytoplasm of the host
cells
T- Cell as well as B-Cell immunity will developed & produced antibody
against the proteins/ keep the mammary
When pathogen (antigen) enters to the host cell, the T-Cells as well as
B cells recognize and killed.
How DNA vaccine plasmids Stimulate immune responses?
More effective at inducing antigen-specific immune responses,
especially cellular responses.
Compared to conventional vaccines, they are much cheaper,
safer, and the mRNA vaccine helped to synthesis of proteins.
When cells are done producing a protein, they swiftly degrade
the mRNA.
Vaccination of mRNA doesn't enter the nucleus and doesn't
change genome
RNA VACCINES
Types including
Non-replicating mRNA, which is the simplest technology; the
pathogen's mRNA strand is packaged with additional RNA strands
that ensure it will be copied once the vaccine is inside a cell.
In vivo self-replicating mRNA, which is the vaccine's mRNA strand.
This means that more antigen may be produced from a lower dose
of vaccination, ensuring a stronger immune response
Dendritic cells that may transfer antigens on their cell surfaces to
other types of immune cells in order to assist trigger an immune
response are known as in vitro dendritic cell non-replicating mRNA
vaccines.
RNA INTERFERNECE (RNAi)
“A process in which the introduction of double-stranded
RNA into a cell inhibits the expression of genes”
Shrimp also use RNA interference as a defense mechanism, when a
virus infects a shrimp, its RNA is recognized and targeted by the
shrimp's RNAi machinery, inhibiting the virus's ability to replicate
Post Translational Gene Silencing
(PTGS) Pathway
ds RNA in the cytoplasm triggers the multi
domain ribonuclease II enzyme DICER which
cleaves the ds RNA in to si RNA which are 21
to 23 nucleotide fragments
These si RNA is recognized by the RNA
induced Silencing complex (RISC), a multi
enzyme unit that brings about separation of
two si RNA stands.
The antisense Si RNA stand remains bound to
RISC while the sense strand is released.
Finally the antisense and RISC complex bind
the target mRNA allowing the nuclease activity
and degraded the target gene
RECOMBINANT SUBUNIT VACCINE
Targeted proteins of a microbial
pathogen expressed through
various expression system to
produce recombinant proteins.
that.
They have lack the capacity to
multiply in the host, making them
non-infectious
Need several immunoadjuvant
booster shots to guarantee long-
lasting protective immunity.
Induce immunity against more
than one strain or serotype of a
bacterial or viral disease by
including multiple proteins in a
subunit vaccination.
Virus-like particles (VLPs), which are subunit vaccine
components, are created when viral capsid proteins self-
assemble into particles that resemble the virus's natural
structure.
VLPs lack genomic content, unlike the genuine viral
particles, ruling out the possibility of reversion mutations
or pathogenic infection.
VLPs—which cannot replicate in the recipient—can
augment both innate and adaptive immune responses.
REVERSE VACCINE
The immunogenic sequences of
infectious diseases are predicted
using a bioinformatics approach
in reverse volcanology used to
develop vaccines.
The whole antigenic repertoire of
the infectious organism's genome
and the identification of many
prospective protective targets are
identified for potential vaccines
This method enables the
identification of previously
unknown and/or rare proteins.
OMP, cytoplasmic membrane, cell
wall, periplasmic, and ECP of the
proteins are relevant for vaccine
candidates
Bioinformatics Databases
Vaxign analysis and PSORTb
V.3.0.2 tuned to examine
transmembrane helices, adhesion
potential, and subcellular
localization.
BepiPred linear epitope prediction
tools predict B-cell epitopes.
Artificial neural network (ANN):
peptide binding ability to MHC
molecules
VirusPloc predicts the sub cellular
localization of viral proteins
Raptorx server produces the most
accurate structure of the protein
and its activities.
EXPRESSION METHODS FOR VACCINE DEVELOPMENT
Bacterial Expression System
Easiest and high levels of expression
for producing recombinant proteins.
E. coli is one of the dominant strains
for and Bacillus brevis, Vibrio
cholerae and Salmonella typhimurium
ofenly expression of antigens.
Clone the desired genes in to specific
protein expression vector such as
pET32a and transform to bacterial
expression host such as BL21DE3
To create the desired protein, the
transformants are multiplied, induced
with the proper inducers, they
expressed recombinant proteins and
then purified.
Bacterial expression systems have several benefits, multiply rapidly,
fast production of proteins with up to 10% of mass, short generation
times and low cost
Few drawbacks as including the lack of post-translational
modification due to lack of nucleus, Golgi complex and Endoplasmic
reticulam improper protein folding, biologically inactive & endotoxin
contamination from host
Yeast is the most economical
eukaryotic expression system for
large scale production of both
endogenous and heterologous
proteins.
Advantages are high cell densities,
ease of growth and manipulation,
proteolysis, well-adapted for
secreting proteins, and post-
translational modifications such as
glycosylations.
Non-pathogenic nature,
comprehensive genome sequence,
well-established genetics, and
intrinsic natural adjuvant, best
model system for creating
vaccines
YEAST EXPRESSION SYSTEM
Galactose induction system which serves as transcriptional
induction system in and potent promoters GAL1, GAL10, JUB1,
SNR52, MET17, TDH3, TPI1, ENO1, and PDC1 are responsible
for high level expression of foreign genes in S. cerevisiae.
Immunogenic genes may clone to the yeast expression vectors
like pESC-URA and transform to competent Yeast cells with
heat shock of 42º C and plated
There is no need of purification, largely scalable, easily
deliverable for oral vaccine and low cost etc.
Saccharomyces cerevisiae, Pichia pastoris, Hansenula
polymorpha, Yarrowia lipolytica, Arxula adeninivorans,
Kluyveromyces lactis, and Schizosaccharomyces pombe are
excellent strains
The extra benefits of yeast cell walls acting as immune
stimulators make them stronger candidates for vaccines.
Because yeast cells contain polysaccharides such as
mannan, beta-1, and 3-D-glucan (BGs), it was thought that
yeast cells were immunogenic
BACULOVIRUS EXPRESSION SYSTEM
Production of recombinant proteins in
insect cells and larvae using
recombinant baculovirus with a
double-stranded circular DNA genome.
The Autographa californica multiple
nucleopolyhedrovirus (AcMNPV) is the
most used baculovirus species for
biotechnological uses.
The large size of its genome gives the
baculovirus ample capacity to
accommodate large amounts of
foreign DNA, including multiple genes.
Inserting foreign genes downstream of
the polyhedron promoter will result in
high level expression upon infection of
permissive cells.
The polyhedron protein is replaced by the foreign gene of interest
and integrated into the viral genome by homologous recombination.
The Spodoptera frugiperda (Sf-9 and Sf-21) cell lines are capable of
producing the recombinant virus easily, and after infection, the
replication cycle is accompanied by the production of the foreign
protein by polyhedron or p10 promoters.
Glycosylation, fatty acid acylation, phosphorylation, and
proteolytic processing are among the post-translational
alterations that insect cells infected with baculovirus are
capable of better quality vaccines.
Other advantages including improved solubility, proper folding
with biological active, higher yields and 90 % efficiency
MAMMALIAN EXPRESSION SYSTEM
Plasmid-based expression such as
adenovirus, vaccinia, retroviral, and
baculovirus vectors, that transfer
the gene into mammalian cells.
Viral-mediated transduction
especially baculo-viruses
technology is an effective method
for achieving protein expression in
mammalian cells that produce
milligrams amounts of protein.
Benefits: Wide range of post-
transnationally modified proteins
with a higher degree of flexibility,
correct protein folding, genuine
glycosylation, carbohydrate
trimming & proper proteolytic
processing
Other alterations may involve carboxylation of glutamic acid
residues, hydroxylation of aspartic acid and asparagine
residues, sulfation of tyrosine residues, phosphorylation of
proteins via cell receptor-protein interaction, fatty acid
acylation and correct assembly of multimeric proteins.
Several proteins such as Red seabream iridovirus's (RSIV)
transmembrane domain (pCMV-569) and structural proteins
(glycoprotein) of spring viraemia of carp virus (SVCV) were
successfully expressed through mammalian cell lines.
MICRO ALGAL EXPRESSION
Chloroplast expression system is a
promising method of producing oral
vaccinations.
Chlamydomonas reinhardtii,
Dunaliella salina, cyanobacteria, and
other microalgae have been treated to
express antigen genes in chloroplasts.
Introducing desired gens into nuclear
or chloroplast genome through
transformation using electroporation,
glass beads micro-particle
bombardment, or agrobacterium-
mediated DNA transfer.
The foreign gene is integrated in to
the chloroplast genome by
homologous recombination
Antigens expressed in the chloroplast or anchored to the
surface of plasma membrane
Benefits: No purification, expensive fermentation, cold storage,
simplicity, safety etc
Additionally, they have health-promoting advantages by high
protein, fatty acids, pigments provide immunogenicity to hosts
fish.
Transgenic Anabaena sp. PCC 7120, which expressed WSSV
VP28 fed L. vannamei PL had higher resistance against WSSV.
Adjuvant has been used to increase the
potency and durability of immune
responses to specific antigens, vaccine
efficacy & reduce the booster doses
Types
Complete Freund's adjuvant (CFA):
Contains killed and dried
Mycobacterium tuberculosis bacteria
includes an oil-based emulsion. Highly
effective to enhancing the immune
response but some demerits such as
inflammation and granuloma formation
Incomplete Freund's Adjuvant (IFA):
Consists of the oil-based emulsion &
less inflammation used for booster
immunizations for CFA
Aluminum hydroxide & aluminum phosphate, are oldest adjuvants
help enhance the prolonged immune response which slowly
releases the antigen
Oil-in-water emulsions like MF59 and AS03 helps to activate
immune cells.
Liposomes are lipid vesicles that can encapsulate antigens
enhance the presentation of the antigen to the immune system
Monophosphoryl Lipid-A (MPLA), a bacterial lipopolysaccharide
(LPS) helps to activates Toll-like receptor 4 (TLR4) on antigen-
presenting cells
Saponins from plants can enhance antigen uptake and
presentation
Cytokines, such as interleukin-12 (IL-12), enhance the
immune response.
Virosomes are lipid vesicles containing viral proteins used to
deliver antigens
Virus-Like Particles (VLPs) are non-infectious particles can
serve as carriers for antigens and stimulate a strong immune
response.
Nucleic acid adjuvants, CpG oligodeoxynucleotides (CpG
ODNs) and double-stranded RNA (dsRNA) activate Toll-like
receptors (TLRs) and other pattern recognition receptors
IMMUNE SYSTEM AND INFLENCE OF VACCINES
FISH IMMUNE SYSTEM (INNATE)
Fish possesses innate and adaptive
immunity for their defense system.
Innate immune system is lack of
immunological memory and has the
physical barriers such as scales, skin,
and mucus that provide protection
against entry of pathogens
Innate immune system initiation by the
interaction between pathogens and
pattern recognition receptors (PRRs)
Toll-like receptors (TLRs) are trans-
membrane proteins receptors detecting /
interact the ligand molecules of
pathogens that culminate innate
immunity
Cytotoxic cells (NCC), NK-like cells
and granulocytes like neutrophils
involved in the innate immunity
Secretion of antimicrobial peptides
(AMPs) against pathogenic
interruption leading to promotion of
mast cell degranulation,
enhancement of phagocytosis and
decreasing fibrinolysis.
In cellular level of innate immunity,
secondary responses were observed
by repeated exposure to the same
pathogen.
Mononuclear phagocytic system
have monocytes/macrophages
helped to eliminate soluble foreign
waste products
Neutrophils, mast and rodlet cells
have the ability of degranulation
against bacterial, viral, protozoan
and fungal pathogens
ADAPTIVE IMMUNE SYSTEM
Delayed but strong and long lasting
for successful vaccination.
Production of antibodies, B and T
cells recognizing and responding to
specific pathogens, production of
cytokines that help coordinate their
immune response
Major Histocompatibility Complex
(MHC), involved in presenting
antigens to T cells, production of
interferons inhibit viral replication
Two major groups of lymphocytes, B cells that mediate antibody
(humoral) responses and T cells that mediate cell-mediated immune
responses.
In antibody responses, B cells are activated to secrete antibodies,
which are soluble forms and circulate in the bloodstream and
permeate the other body fluids, bind specifically to the foreign
antigen
Binding of antibody inactivates viruses and microbial toxins by
blocking their ability to bind to receptors on host cells and
destructing the invading pathogens.
Cell-mediated immunity, antigen-specific T cells are activated
that react directly against a foreign antigen
Unlike B cells, T cells can only recognize antigen that has been
processed and presented by antigen-presenting cells via their
MHC proteins.
T cells can kill, virus-infected host cells that have viral
antigens on their surface, thereby eliminating the infected cells
before the virus has had a chance to replicate.
SHRIMP IMMUNE SYSTEM
Unlike fishes, shrimp have
primitive type of innate immune
system and have lack of adaptive
immune system.
It includes physical barriers like
the exoskeleton that provides
protection against external threats.
They have humoral and cell
mediated immunity that help
recognize and destroy pathogens.
Coagulation is preventing
hemolymph loss by clotting
protein will trap microorganisms
during coagulation and this
reaction is catalysed by a
Transglutamase released from the
hemocytes.
Hemocytes play a crucial role for
phagocytosis by engulfing and digesting
pathogens, encapsulation and the
production of antimicrobial peptides.
Prophenoloxidase (ProPO) encounters a
pathogen, the ProPO system is activated,
leading to the production of melanin and the
formation of melanized nodules, which help
encapsulate and neutralize the invading
microorganisms.
They also stimulate several cellular defence
reactions, including phagocytosis, nodule
formation, encapsulation, and haemocyte
locomotion.
Activated haemocytes also produce extra
bactericidal substances, such as superoxide
anion (O2-), lysozyme that may increase
disease resistance and activation of Toll
Like Receptors (TLR).
Pattern Recognition Receptors
(PRRs) have the ability to the
interaction between host and
pathogen could be stimulate
immunity
Toll-like receptors (TLRs), has
the ability to recognize a wide
range of pathogen-associated
molecules patterns (PAMPs).
After recognizing PAMPs, TLRs
genes will trigger the innate
immunity of the shrimp by
initiating the signalling of TLRs
pathway (TLR-MYD88-TNRF)
followed by the AMP and proPO
cascade.
RNA interference as a defense
mechanism, inhibiting the virus's
ability to replicate.
Short immune memory, lack of true
immunoglobulin, but a short
memory of antigen as the immune
response might involve an induced
secretion of neutralizing substances
or defence proteins against
pathogenic interruption.
Quasi-immune response has been
reported against WSSV in
Marsupenaeus japonicas, resistance
against WSSV appeared 3 weeks
after the virus exposure and was
maintained for about 1 month, which
was endorsed by the appearance of
virus neutralizing factor(s) in the
haemolymph of immunized shrimp.
Shell Fishes
Innate immune system
No clear responses
No antibody production
Pathogen persists
Infectious to others
Humoral immunity
AMP, PO & Coagulation
Cellular immunity
Encap., nodule & pago.
Adaptive immune system
Specific responses
Antibody produced
Pathogen eliminated
May or may not
Humoral immunity
B cells
Cellular immunity
T cells
Fin Fishes
IMMUNE SYSTEM OF SHRIMP VS FISH
DELIVERY METHODS
Delivery method depends on various factors, including the fish
species, size, specific disease & age
Injection: Intra-peritoneal injection into the peritoneal cavity;
Intramuscular injection into the muscle tissue used for larger fish
species.
Oral vaccines, it may be inactivated bacterial/viral cells or bacterial
transformants with recombinants coated with feed pellets with oil
& feed them
Bio-encapsulation: Inactivated cells and recombinant bacterial
transformants encapsulated with Artemia or rotifer and feeding to
fish larvae
Immersion bath: Fish immersed in a solution containing the
vaccine for a specific period especially for smaller fish and
stress-free
Immersion vaccination: Fish/shrimp are coated with a vaccine
suspension for a brief period, skin & gills absorb the vaccine
Spray vaccines: Vaccine solution is sprayed onto the fish's
skin or nostrils, helps to absorbing the vaccines, for skin &
gills infection.
Recombinant or transgenic microalgae with expressing viral
and bacterial proteins are directly feeding to the fish and
shrimp larvae.
NANO DELIVERY
Facilitate controlled release, target-
based drug delivery, improve
biocompatibility and
biodegradability.
Proteins, hydrophobic and
hydrophilic biological
macromolecules, peptides, DNA
vaccines and other substances are
all delivered via nanoparticles.
This delivery improve adjuvant or
antigen uptake by APCs, resulting
greater immune responses.
Peptides, cell lysates, DNA
vaccines, and lipo-peptides have
been conjugated with Poly (Lactic –
co-Glycolic Acid) nanoparticles.
Natural polymers: Created through physical and chemical
processes, are extremely biocompatible for drug delivery.
Chitosan, starch, alginate, cellulose, hyaluronic acid, chondroitin
sulphate, and other extensively used natural polymer ingredients.
Chitoson have several advantages like biodegradability, excellent
biocompatibility, the ability to be functionalized, antibacterial
capabilities, and natural processability.
Tripolyphosphate (TPP), a cross-linking agent, has been added to
the aqueous phase containing chitosan in a method for creating
chitosan nanogels, absorbed into fish cells also useful to siRNA
delivery
CONCLUSIONS & FUTURE DIRECTIONS
Utilizing the advanced biotechnological tools and expression
system resulted efficient recombinant vaccine may produce
and this will solve almost disease outbreaks.
Advantages: Proper post translational modification and protein
folding that gives strong and effective immunity
Edible vaccine like IgY has been numerous benefits, including
lower cost, greater convenience, and less invasiveness
Transgenic micro algae has been expressing immunogenic
proteins are highly valuable and effective against bacterial and
viral pathogens especially to the Fish/shrimp young ones
Nano-based delivery is powerful tools have so many
advantages including controlled release of antigens and long
lasting immunity
THANK YOU

More Related Content

Similar to Aquatic Vaccines.ppt

Vaccines
VaccinesVaccines
Vaccines
Mehvishgcufgcuf
 
Vaccines
VaccinesVaccines
Vaccines
Mehvishgcufgcuf
 
Advance vaccine adjuvant
Advance vaccine adjuvantAdvance vaccine adjuvant
Advance vaccine adjuvantTrupti Mayee
 
Vaccine development (1).pptx
Vaccine development (1).pptxVaccine development (1).pptx
Vaccine development (1).pptx
MazedurRahman17
 
vaccine & vaccination.pptx
vaccine & vaccination.pptxvaccine & vaccination.pptx
vaccine & vaccination.pptx
Sakun Rasaily
 
vaccines vaccination
vaccines vaccinationvaccines vaccination
vaccines vaccination
SNEHADAS123
 
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
SYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINESYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINE
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
D.R. Chandravanshi
 
Vaccines
VaccinesVaccines
Vaccines
HinaShoukat2
 
Vaccines
VaccinesVaccines
Vaccines
Saranraj P
 
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptxBIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
Alok Kumar
 
Vaccination-A Veterinarian Perspective
Vaccination-A Veterinarian PerspectiveVaccination-A Veterinarian Perspective
Vaccination-A Veterinarian Perspective
Haroon Rashid Chaudhry
 
Vaccine delivery systems
Vaccine delivery systemsVaccine delivery systems
Vaccine delivery systems
JayeshRajput7
 
DNA Vaccine.pptx
DNA Vaccine.pptxDNA Vaccine.pptx
DNA Vaccine.pptx
Rachana Choudhary
 
New generation vaccines production
New generation vaccines productionNew generation vaccines production
New generation vaccines production
D.R. Chandravanshi
 
new generation vaccine.pptx
new generation vaccine.pptxnew generation vaccine.pptx
new generation vaccine.pptx
IqraIqra72
 
new generation vaccine.pptx
new generation vaccine.pptxnew generation vaccine.pptx
new generation vaccine.pptx
IqraIqra72
 
new generation vaccine technology .pptx
new generation vaccine technology  .pptxnew generation vaccine technology  .pptx
new generation vaccine technology .pptx
Anh Nguyen
 
COVID-19 VACCINES
COVID-19 VACCINESCOVID-19 VACCINES
COVID-19 VACCINES
imaging_70
 
Vaccines (immunotherapy) & COVID-19 Overview
Vaccines (immunotherapy) & COVID-19 OverviewVaccines (immunotherapy) & COVID-19 Overview
Vaccines (immunotherapy) & COVID-19 Overview
Rishab Malhotra
 
Vaccines & immunomodulation
Vaccines & immunomodulationVaccines & immunomodulation
Vaccines & immunomodulation
Dr Alok Tripathi
 

Similar to Aquatic Vaccines.ppt (20)

Vaccines
VaccinesVaccines
Vaccines
 
Vaccines
VaccinesVaccines
Vaccines
 
Advance vaccine adjuvant
Advance vaccine adjuvantAdvance vaccine adjuvant
Advance vaccine adjuvant
 
Vaccine development (1).pptx
Vaccine development (1).pptxVaccine development (1).pptx
Vaccine development (1).pptx
 
vaccine & vaccination.pptx
vaccine & vaccination.pptxvaccine & vaccination.pptx
vaccine & vaccination.pptx
 
vaccines vaccination
vaccines vaccinationvaccines vaccination
vaccines vaccination
 
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
SYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINESYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINE
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
 
Vaccines
VaccinesVaccines
Vaccines
 
Vaccines
VaccinesVaccines
Vaccines
 
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptxBIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
 
Vaccination-A Veterinarian Perspective
Vaccination-A Veterinarian PerspectiveVaccination-A Veterinarian Perspective
Vaccination-A Veterinarian Perspective
 
Vaccine delivery systems
Vaccine delivery systemsVaccine delivery systems
Vaccine delivery systems
 
DNA Vaccine.pptx
DNA Vaccine.pptxDNA Vaccine.pptx
DNA Vaccine.pptx
 
New generation vaccines production
New generation vaccines productionNew generation vaccines production
New generation vaccines production
 
new generation vaccine.pptx
new generation vaccine.pptxnew generation vaccine.pptx
new generation vaccine.pptx
 
new generation vaccine.pptx
new generation vaccine.pptxnew generation vaccine.pptx
new generation vaccine.pptx
 
new generation vaccine technology .pptx
new generation vaccine technology  .pptxnew generation vaccine technology  .pptx
new generation vaccine technology .pptx
 
COVID-19 VACCINES
COVID-19 VACCINESCOVID-19 VACCINES
COVID-19 VACCINES
 
Vaccines (immunotherapy) & COVID-19 Overview
Vaccines (immunotherapy) & COVID-19 OverviewVaccines (immunotherapy) & COVID-19 Overview
Vaccines (immunotherapy) & COVID-19 Overview
 
Vaccines & immunomodulation
Vaccines & immunomodulationVaccines & immunomodulation
Vaccines & immunomodulation
 

More from Thavasimuthu citarasu

Aquatic Disease Diagnosis.ppt
Aquatic Disease Diagnosis.pptAquatic Disease Diagnosis.ppt
Aquatic Disease Diagnosis.ppt
Thavasimuthu citarasu
 
Biotechnological approaches in aquatic animal health management
Biotechnological approaches in aquatic animal health managementBiotechnological approaches in aquatic animal health management
Biotechnological approaches in aquatic animal health management
Thavasimuthu citarasu
 
Marine Science and Marine Biotechnology
Marine Science and Marine Biotechnology Marine Science and Marine Biotechnology
Marine Science and Marine Biotechnology
Thavasimuthu citarasu
 
Citarasu mku ref_2020
Citarasu mku ref_2020Citarasu mku ref_2020
Citarasu mku ref_2020
Thavasimuthu citarasu
 
Marine Bio-Prospecting
Marine Bio-Prospecting Marine Bio-Prospecting
Marine Bio-Prospecting
Thavasimuthu citarasu
 
Citarasu holycross
Citarasu holycrossCitarasu holycross
Citarasu holycross
Thavasimuthu citarasu
 
Citarasu tnjfu 2020
Citarasu tnjfu 2020Citarasu tnjfu 2020
Citarasu tnjfu 2020
Thavasimuthu citarasu
 
Citarasu rdfa aks_2020
Citarasu rdfa aks_2020Citarasu rdfa aks_2020
Citarasu rdfa aks_2020
Thavasimuthu citarasu
 
SHRIMP HEALTH MANAGEMENT
SHRIMP HEALTH MANAGEMENTSHRIMP HEALTH MANAGEMENT
SHRIMP HEALTH MANAGEMENT
Thavasimuthu citarasu
 
Citarasu biogen 2019
Citarasu biogen 2019Citarasu biogen 2019
Citarasu biogen 2019
Thavasimuthu citarasu
 
Algal natural products
Algal natural productsAlgal natural products
Algal natural products
Thavasimuthu citarasu
 
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
Thavasimuthu citarasu
 
Marine Natural Products and Health
 Marine Natural Products and Health  Marine Natural Products and Health
Marine Natural Products and Health
Thavasimuthu citarasu
 
Citarasu cas
Citarasu casCitarasu cas
Citarasu cas
Thavasimuthu citarasu
 
Bioprospecting
BioprospectingBioprospecting
Bioprospecting
Thavasimuthu citarasu
 
Cmst forum
Cmst forumCmst forum
Trends in mbt holycross
Trends in mbt holycrossTrends in mbt holycross
Trends in mbt holycross
Thavasimuthu citarasu
 
Marine pollution sth
Marine pollution sthMarine pollution sth
Marine pollution sth
Thavasimuthu citarasu
 

More from Thavasimuthu citarasu (18)

Aquatic Disease Diagnosis.ppt
Aquatic Disease Diagnosis.pptAquatic Disease Diagnosis.ppt
Aquatic Disease Diagnosis.ppt
 
Biotechnological approaches in aquatic animal health management
Biotechnological approaches in aquatic animal health managementBiotechnological approaches in aquatic animal health management
Biotechnological approaches in aquatic animal health management
 
Marine Science and Marine Biotechnology
Marine Science and Marine Biotechnology Marine Science and Marine Biotechnology
Marine Science and Marine Biotechnology
 
Citarasu mku ref_2020
Citarasu mku ref_2020Citarasu mku ref_2020
Citarasu mku ref_2020
 
Marine Bio-Prospecting
Marine Bio-Prospecting Marine Bio-Prospecting
Marine Bio-Prospecting
 
Citarasu holycross
Citarasu holycrossCitarasu holycross
Citarasu holycross
 
Citarasu tnjfu 2020
Citarasu tnjfu 2020Citarasu tnjfu 2020
Citarasu tnjfu 2020
 
Citarasu rdfa aks_2020
Citarasu rdfa aks_2020Citarasu rdfa aks_2020
Citarasu rdfa aks_2020
 
SHRIMP HEALTH MANAGEMENT
SHRIMP HEALTH MANAGEMENTSHRIMP HEALTH MANAGEMENT
SHRIMP HEALTH MANAGEMENT
 
Citarasu biogen 2019
Citarasu biogen 2019Citarasu biogen 2019
Citarasu biogen 2019
 
Algal natural products
Algal natural productsAlgal natural products
Algal natural products
 
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
MARINE POLLUTION THREATS AND BIODIVERSITY CONSERVATION
 
Marine Natural Products and Health
 Marine Natural Products and Health  Marine Natural Products and Health
Marine Natural Products and Health
 
Citarasu cas
Citarasu casCitarasu cas
Citarasu cas
 
Bioprospecting
BioprospectingBioprospecting
Bioprospecting
 
Cmst forum
Cmst forumCmst forum
Cmst forum
 
Trends in mbt holycross
Trends in mbt holycrossTrends in mbt holycross
Trends in mbt holycross
 
Marine pollution sth
Marine pollution sthMarine pollution sth
Marine pollution sth
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 

Aquatic Vaccines.ppt

  • 1. Dr. T. Citarasu Associate Professor Tele-fax: + 91-4652-253078 Mobile: +91-9994273822 Email: citarasu@gmail.com citarasu@msuniv.ac.in Website: www.msuniv.ac.in www.msuniv.irins.org/profile/174278 CENTRE FOR MARINE SCIENCE AND TECHNOLOGY MANONMANIAM SUNDARANAR UNIVERSITY, TIRUNELVELI
  • 3. Chemotherapy and antibiotics are giving positive effects for treating disease, there are some drawbacks, such as residual problem, resistance strain development, bio magnification and host immune system suppression etc. Considering the potential threats of diseases on one side and environmental issues on the other side, attention should be focused to developing alternative practices for solving problems such as vaccine and immunostimulants. Development of immunostimulation and vaccines with advanced protocols are effective to boost the immune system against bacterial, viral and parasitic diseases. NEED OF VACCINES
  • 4. THE CRUCIAL TRAITS OF AQUACULTURE VACCINES Induce long-lasting protective immune memory and preventative immunity Elicit humoral and cell - mediated immunological responses in the host B cells store the memory and trigger the immunity when subsequent exposure of pathogens A vaccination is deemed safe if it immunizes in a manner similar to a natural infection but does not negative side effects, and the fish vaccine must be risk-free for the final consumer Must be good protection, stress free and time efficient with mass immunization Equally effective in multiple fish species and cost-effectiveness make profit
  • 6. FIRST GENERATION OF VACCINES First-generation vaccinations are forms of microbial pathogens like live, weakened, and killed bacteria and viruses. They do not trigger cell-mediated immune responses; only humoral immune responses are elicited. Live-attenuated vaccines contain live microorganisms that have been "weakened" or rendered incapable of causing disease but some occasions they revert their virulence Self-replicating qualities of live vaccines they do not require booster dose Genetic attenuation by mutation (deletion, disruption of the metabolic pathway or virulence gene); chemical (formaldehyde) & physical (heat and UV radiation)
  • 7. Contains defined protein antigens or recombinant protein components capable of inducing humoral and cell mediated immune responses, particularly T helper antibody responses Antigens are crude proteins extracted and purified from pathogens and also specific immunogenic proteins can be expressed and purified using different recombinant expression systems Antigenic components are unable to proliferate in the host and no threat of pathogenicity to the host SECOND GENERATION OF VACCINES
  • 8. Examples of bacterial extra cellular toxins like haemolysin, bacterial outer membrane protein (OMP), viral envelop protein etc. They are incredibly safe method of vaccination and are less side effects. They have the ability to elicit an immune response and mount immunological response and memory. Multiple doses of the subunit vaccinations may be necessary, and immunological adjuvant is required for effective generation of antibodies
  • 9. THIRD GENERATION OF VACCINE A short, circular piece of bacterial DNA (plasmid) that has been genetically modified to create one or two specific proteins (antigens) from a microorganism makes up DNA vaccines, which are third-generation vaccinations. Host cells receive the vaccine DNA and the "inner machinery" of the host cells "reads" the DNA to produce corresponding target proteins. The host cells process them and expose them on their surface, the immune system is notified and causes a variety of humoral and cell- mediated powerful and long-lasting immune responses to be triggered
  • 10. CONVENTIONAL VACCINES AND THEIR DRAWBACKS Unfortunately, they have several drawbacks, such as a week or shorter immunity, reversal of virulence, ineffectiveness, heat liability, etc. The risk of new strains emerging from recombination of various strains in live attenuated vaccines exists. In order to retain an acceptable degree of protective immunity for a longer period of time and enhance their efficiency, inactivated vaccines require multiple booster doses, proper adjuvant, etc.
  • 11. Typically, inactivated vaccines are ineffective against viral infections and intracellular microorganisms Physical or chemical treatments that result in denaturation of the proteins or damage to the nucleic acids in inactivated and killed vaccines Also toxoid vaccines mixed with immune adjuvant are effective but high level bio safety is required
  • 13. NON EXPRESSED VACCINES Subunit Vaccines The short, specialized proteins of a pathogen that is non-infectious because they cannot reproduce in the host and promote strong immunological response By directly extracting the native protein from pathogen cultures, subunit vaccines can be made. By include more than one protein in a subunit vaccine; it is possible to establish immunity against more than one strain or serotype of a bacterial or viral disease.
  • 14. S/A-layer proteins, extracellular products (ECP), outer membrane proteins (OMP), synthetic peptides, & lipopolysachharides (LPS) are common examples of subunit proteins. When administered by injection along with an immunoadjuvant, they are more efficient. They have some drawbacks, such as the need for immunoadjuvants and the need for precise understanding of the epitope structure of the protective antigens of the pathogen for the vaccine. Non expressed subunit vaccines have the drawback of having a low level of immunogenicity, requiring more doses and immuno-adjuvants
  • 15. BIOFILM VACCINE Cells embedded in a matrix create biofilms; structures that help bacteria adapt to various micro niches and endure harsh environmental circumstances. Bacterial cells within the biofilm and those located in its matrix, which includes polysaccharides, extracellular proteins, and DNA, are key sources of biofilm antigens. The extracellular matrix, also known as extracellular polymeric substances, or EPS, which is made up of proteins, lipids, exopolysaccharides, and extracellular DNA (eDNA), surrounds the biofilm bacterium.
  • 16. Biofilm antigens obtained from several bacterial pathogens were highly influenced to boost the immune system in fish species Oral biofilm vaccines have been confirmed to have protective effects for many fish, such as, Lates calcarifer, Labeo rohita , Oreochromis sp., Cyprinus carpio, and Mugil cephalus The TLR 3, IL-1, and IL-8 genes were up-regulated in the vaccinated fish 28 days after immunization, which increased survival and immunological parameter
  • 17. EGG YOLK EDIBLE VACCINE IgY When chickens are faced with a foreign virus or bacterium, they produce antibodies to fight the invader. They pass that immunity on to their offspring, and antibodies wind up in the eggs. 1. Chickens are more apt than mammals to make high-avidity antibodies 2. A single chicken can produce an enormous amount of antibody, up to 3 grams of IgY per month, which is 10-20 times the amount of a rabbit 3. Chickens produce antibody much quicker-high-titre antibody is available from eggs as early as day 25 4. Storing of eggs (antibodies) is very easy
  • 18. APPLICATIONS AND ADVANTAGES Research , diagnostics & therapy High specificity to target antigens Less cross reactivity compared with mammalian antibody Potential therapeutic applications, such as passive immunization Effective against drug-resistant bacteria. It is cheaper to feed and house chickens than rabbits
  • 19. GENETICALLY ALTERED VACCINES By deleting, disrupting, or altering the metabolic pathway or virulence genes that causes attenuation in pathogens used as live-attenuated vaccinations. This modification aids in turning a pathogen into non-pathogenic and produces a host's protective immune response. Attenuated live vaccines against Streptococcus iniae, Vibrio anguillarum, Flavobacterium columnare, Edwardsiella ictaluri, A. hydrophila and E. tarda. Effective, but due to some of the safety concerns, mostly not accepted for aquaculture operations.
  • 20. VECTORS EXPRESSED VACCINES DNA VACCINE The ability of DNA vaccines to trigger both cellular and humoral immune responses that provide meaningful protection against fish diseases is one of its numerous advantages over conventional immunization techniques. Immunization with a circular piece of DNA that code for an antigen Plasmids consist of strong viral promoter (SV-40/CMV ) to drive the in vivo transcription and translation of gene interest.
  • 21. Intron A may sometimes be included to improve mRNA stability and hence increase protein expression. Plasmids also include a strong polyadenylation/transcriptional termination signal, such as bovine growth hormone or rabbit beta-globulin polyadenylation sequences. Multi-cistronic vectors are sometimes constructed to express more than one immunogen, or to express an immunogen and an immunostimulatory protein
  • 22. Recombinant plasmids enter to the host cell Gene of interest is transcribed by the RNA polymerase II & synthesis of messenger RNA (mRNA) Translated into the corresponding protein in the cytoplasm of the host cells T- Cell as well as B-Cell immunity will developed & produced antibody against the proteins/ keep the mammary When pathogen (antigen) enters to the host cell, the T-Cells as well as B cells recognize and killed. How DNA vaccine plasmids Stimulate immune responses?
  • 23. More effective at inducing antigen-specific immune responses, especially cellular responses. Compared to conventional vaccines, they are much cheaper, safer, and the mRNA vaccine helped to synthesis of proteins. When cells are done producing a protein, they swiftly degrade the mRNA. Vaccination of mRNA doesn't enter the nucleus and doesn't change genome RNA VACCINES
  • 24. Types including Non-replicating mRNA, which is the simplest technology; the pathogen's mRNA strand is packaged with additional RNA strands that ensure it will be copied once the vaccine is inside a cell. In vivo self-replicating mRNA, which is the vaccine's mRNA strand. This means that more antigen may be produced from a lower dose of vaccination, ensuring a stronger immune response Dendritic cells that may transfer antigens on their cell surfaces to other types of immune cells in order to assist trigger an immune response are known as in vitro dendritic cell non-replicating mRNA vaccines.
  • 25. RNA INTERFERNECE (RNAi) “A process in which the introduction of double-stranded RNA into a cell inhibits the expression of genes” Shrimp also use RNA interference as a defense mechanism, when a virus infects a shrimp, its RNA is recognized and targeted by the shrimp's RNAi machinery, inhibiting the virus's ability to replicate
  • 26. Post Translational Gene Silencing (PTGS) Pathway ds RNA in the cytoplasm triggers the multi domain ribonuclease II enzyme DICER which cleaves the ds RNA in to si RNA which are 21 to 23 nucleotide fragments These si RNA is recognized by the RNA induced Silencing complex (RISC), a multi enzyme unit that brings about separation of two si RNA stands. The antisense Si RNA stand remains bound to RISC while the sense strand is released. Finally the antisense and RISC complex bind the target mRNA allowing the nuclease activity and degraded the target gene
  • 27. RECOMBINANT SUBUNIT VACCINE Targeted proteins of a microbial pathogen expressed through various expression system to produce recombinant proteins. that. They have lack the capacity to multiply in the host, making them non-infectious Need several immunoadjuvant booster shots to guarantee long- lasting protective immunity. Induce immunity against more than one strain or serotype of a bacterial or viral disease by including multiple proteins in a subunit vaccination.
  • 28. Virus-like particles (VLPs), which are subunit vaccine components, are created when viral capsid proteins self- assemble into particles that resemble the virus's natural structure. VLPs lack genomic content, unlike the genuine viral particles, ruling out the possibility of reversion mutations or pathogenic infection. VLPs—which cannot replicate in the recipient—can augment both innate and adaptive immune responses.
  • 29. REVERSE VACCINE The immunogenic sequences of infectious diseases are predicted using a bioinformatics approach in reverse volcanology used to develop vaccines. The whole antigenic repertoire of the infectious organism's genome and the identification of many prospective protective targets are identified for potential vaccines This method enables the identification of previously unknown and/or rare proteins. OMP, cytoplasmic membrane, cell wall, periplasmic, and ECP of the proteins are relevant for vaccine candidates
  • 30. Bioinformatics Databases Vaxign analysis and PSORTb V.3.0.2 tuned to examine transmembrane helices, adhesion potential, and subcellular localization. BepiPred linear epitope prediction tools predict B-cell epitopes. Artificial neural network (ANN): peptide binding ability to MHC molecules VirusPloc predicts the sub cellular localization of viral proteins Raptorx server produces the most accurate structure of the protein and its activities.
  • 31. EXPRESSION METHODS FOR VACCINE DEVELOPMENT Bacterial Expression System Easiest and high levels of expression for producing recombinant proteins. E. coli is one of the dominant strains for and Bacillus brevis, Vibrio cholerae and Salmonella typhimurium ofenly expression of antigens. Clone the desired genes in to specific protein expression vector such as pET32a and transform to bacterial expression host such as BL21DE3 To create the desired protein, the transformants are multiplied, induced with the proper inducers, they expressed recombinant proteins and then purified.
  • 32. Bacterial expression systems have several benefits, multiply rapidly, fast production of proteins with up to 10% of mass, short generation times and low cost Few drawbacks as including the lack of post-translational modification due to lack of nucleus, Golgi complex and Endoplasmic reticulam improper protein folding, biologically inactive & endotoxin contamination from host
  • 33. Yeast is the most economical eukaryotic expression system for large scale production of both endogenous and heterologous proteins. Advantages are high cell densities, ease of growth and manipulation, proteolysis, well-adapted for secreting proteins, and post- translational modifications such as glycosylations. Non-pathogenic nature, comprehensive genome sequence, well-established genetics, and intrinsic natural adjuvant, best model system for creating vaccines YEAST EXPRESSION SYSTEM
  • 34. Galactose induction system which serves as transcriptional induction system in and potent promoters GAL1, GAL10, JUB1, SNR52, MET17, TDH3, TPI1, ENO1, and PDC1 are responsible for high level expression of foreign genes in S. cerevisiae. Immunogenic genes may clone to the yeast expression vectors like pESC-URA and transform to competent Yeast cells with heat shock of 42º C and plated There is no need of purification, largely scalable, easily deliverable for oral vaccine and low cost etc.
  • 35. Saccharomyces cerevisiae, Pichia pastoris, Hansenula polymorpha, Yarrowia lipolytica, Arxula adeninivorans, Kluyveromyces lactis, and Schizosaccharomyces pombe are excellent strains The extra benefits of yeast cell walls acting as immune stimulators make them stronger candidates for vaccines. Because yeast cells contain polysaccharides such as mannan, beta-1, and 3-D-glucan (BGs), it was thought that yeast cells were immunogenic
  • 36. BACULOVIRUS EXPRESSION SYSTEM Production of recombinant proteins in insect cells and larvae using recombinant baculovirus with a double-stranded circular DNA genome. The Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is the most used baculovirus species for biotechnological uses. The large size of its genome gives the baculovirus ample capacity to accommodate large amounts of foreign DNA, including multiple genes. Inserting foreign genes downstream of the polyhedron promoter will result in high level expression upon infection of permissive cells.
  • 37. The polyhedron protein is replaced by the foreign gene of interest and integrated into the viral genome by homologous recombination. The Spodoptera frugiperda (Sf-9 and Sf-21) cell lines are capable of producing the recombinant virus easily, and after infection, the replication cycle is accompanied by the production of the foreign protein by polyhedron or p10 promoters.
  • 38. Glycosylation, fatty acid acylation, phosphorylation, and proteolytic processing are among the post-translational alterations that insect cells infected with baculovirus are capable of better quality vaccines. Other advantages including improved solubility, proper folding with biological active, higher yields and 90 % efficiency
  • 39. MAMMALIAN EXPRESSION SYSTEM Plasmid-based expression such as adenovirus, vaccinia, retroviral, and baculovirus vectors, that transfer the gene into mammalian cells. Viral-mediated transduction especially baculo-viruses technology is an effective method for achieving protein expression in mammalian cells that produce milligrams amounts of protein. Benefits: Wide range of post- transnationally modified proteins with a higher degree of flexibility, correct protein folding, genuine glycosylation, carbohydrate trimming & proper proteolytic processing
  • 40. Other alterations may involve carboxylation of glutamic acid residues, hydroxylation of aspartic acid and asparagine residues, sulfation of tyrosine residues, phosphorylation of proteins via cell receptor-protein interaction, fatty acid acylation and correct assembly of multimeric proteins. Several proteins such as Red seabream iridovirus's (RSIV) transmembrane domain (pCMV-569) and structural proteins (glycoprotein) of spring viraemia of carp virus (SVCV) were successfully expressed through mammalian cell lines.
  • 41. MICRO ALGAL EXPRESSION Chloroplast expression system is a promising method of producing oral vaccinations. Chlamydomonas reinhardtii, Dunaliella salina, cyanobacteria, and other microalgae have been treated to express antigen genes in chloroplasts. Introducing desired gens into nuclear or chloroplast genome through transformation using electroporation, glass beads micro-particle bombardment, or agrobacterium- mediated DNA transfer. The foreign gene is integrated in to the chloroplast genome by homologous recombination
  • 42. Antigens expressed in the chloroplast or anchored to the surface of plasma membrane Benefits: No purification, expensive fermentation, cold storage, simplicity, safety etc Additionally, they have health-promoting advantages by high protein, fatty acids, pigments provide immunogenicity to hosts fish. Transgenic Anabaena sp. PCC 7120, which expressed WSSV VP28 fed L. vannamei PL had higher resistance against WSSV.
  • 43. Adjuvant has been used to increase the potency and durability of immune responses to specific antigens, vaccine efficacy & reduce the booster doses Types Complete Freund's adjuvant (CFA): Contains killed and dried Mycobacterium tuberculosis bacteria includes an oil-based emulsion. Highly effective to enhancing the immune response but some demerits such as inflammation and granuloma formation Incomplete Freund's Adjuvant (IFA): Consists of the oil-based emulsion & less inflammation used for booster immunizations for CFA
  • 44. Aluminum hydroxide & aluminum phosphate, are oldest adjuvants help enhance the prolonged immune response which slowly releases the antigen Oil-in-water emulsions like MF59 and AS03 helps to activate immune cells. Liposomes are lipid vesicles that can encapsulate antigens enhance the presentation of the antigen to the immune system Monophosphoryl Lipid-A (MPLA), a bacterial lipopolysaccharide (LPS) helps to activates Toll-like receptor 4 (TLR4) on antigen- presenting cells Saponins from plants can enhance antigen uptake and presentation
  • 45. Cytokines, such as interleukin-12 (IL-12), enhance the immune response. Virosomes are lipid vesicles containing viral proteins used to deliver antigens Virus-Like Particles (VLPs) are non-infectious particles can serve as carriers for antigens and stimulate a strong immune response. Nucleic acid adjuvants, CpG oligodeoxynucleotides (CpG ODNs) and double-stranded RNA (dsRNA) activate Toll-like receptors (TLRs) and other pattern recognition receptors
  • 46. IMMUNE SYSTEM AND INFLENCE OF VACCINES FISH IMMUNE SYSTEM (INNATE) Fish possesses innate and adaptive immunity for their defense system. Innate immune system is lack of immunological memory and has the physical barriers such as scales, skin, and mucus that provide protection against entry of pathogens Innate immune system initiation by the interaction between pathogens and pattern recognition receptors (PRRs) Toll-like receptors (TLRs) are trans- membrane proteins receptors detecting / interact the ligand molecules of pathogens that culminate innate immunity
  • 47. Cytotoxic cells (NCC), NK-like cells and granulocytes like neutrophils involved in the innate immunity Secretion of antimicrobial peptides (AMPs) against pathogenic interruption leading to promotion of mast cell degranulation, enhancement of phagocytosis and decreasing fibrinolysis. In cellular level of innate immunity, secondary responses were observed by repeated exposure to the same pathogen. Mononuclear phagocytic system have monocytes/macrophages helped to eliminate soluble foreign waste products
  • 48. Neutrophils, mast and rodlet cells have the ability of degranulation against bacterial, viral, protozoan and fungal pathogens ADAPTIVE IMMUNE SYSTEM Delayed but strong and long lasting for successful vaccination. Production of antibodies, B and T cells recognizing and responding to specific pathogens, production of cytokines that help coordinate their immune response Major Histocompatibility Complex (MHC), involved in presenting antigens to T cells, production of interferons inhibit viral replication
  • 49. Two major groups of lymphocytes, B cells that mediate antibody (humoral) responses and T cells that mediate cell-mediated immune responses. In antibody responses, B cells are activated to secrete antibodies, which are soluble forms and circulate in the bloodstream and permeate the other body fluids, bind specifically to the foreign antigen Binding of antibody inactivates viruses and microbial toxins by blocking their ability to bind to receptors on host cells and destructing the invading pathogens.
  • 50. Cell-mediated immunity, antigen-specific T cells are activated that react directly against a foreign antigen Unlike B cells, T cells can only recognize antigen that has been processed and presented by antigen-presenting cells via their MHC proteins. T cells can kill, virus-infected host cells that have viral antigens on their surface, thereby eliminating the infected cells before the virus has had a chance to replicate.
  • 51. SHRIMP IMMUNE SYSTEM Unlike fishes, shrimp have primitive type of innate immune system and have lack of adaptive immune system. It includes physical barriers like the exoskeleton that provides protection against external threats. They have humoral and cell mediated immunity that help recognize and destroy pathogens. Coagulation is preventing hemolymph loss by clotting protein will trap microorganisms during coagulation and this reaction is catalysed by a Transglutamase released from the hemocytes.
  • 52. Hemocytes play a crucial role for phagocytosis by engulfing and digesting pathogens, encapsulation and the production of antimicrobial peptides. Prophenoloxidase (ProPO) encounters a pathogen, the ProPO system is activated, leading to the production of melanin and the formation of melanized nodules, which help encapsulate and neutralize the invading microorganisms. They also stimulate several cellular defence reactions, including phagocytosis, nodule formation, encapsulation, and haemocyte locomotion. Activated haemocytes also produce extra bactericidal substances, such as superoxide anion (O2-), lysozyme that may increase disease resistance and activation of Toll Like Receptors (TLR).
  • 53. Pattern Recognition Receptors (PRRs) have the ability to the interaction between host and pathogen could be stimulate immunity Toll-like receptors (TLRs), has the ability to recognize a wide range of pathogen-associated molecules patterns (PAMPs). After recognizing PAMPs, TLRs genes will trigger the innate immunity of the shrimp by initiating the signalling of TLRs pathway (TLR-MYD88-TNRF) followed by the AMP and proPO cascade.
  • 54. RNA interference as a defense mechanism, inhibiting the virus's ability to replicate. Short immune memory, lack of true immunoglobulin, but a short memory of antigen as the immune response might involve an induced secretion of neutralizing substances or defence proteins against pathogenic interruption. Quasi-immune response has been reported against WSSV in Marsupenaeus japonicas, resistance against WSSV appeared 3 weeks after the virus exposure and was maintained for about 1 month, which was endorsed by the appearance of virus neutralizing factor(s) in the haemolymph of immunized shrimp.
  • 55. Shell Fishes Innate immune system No clear responses No antibody production Pathogen persists Infectious to others Humoral immunity AMP, PO & Coagulation Cellular immunity Encap., nodule & pago. Adaptive immune system Specific responses Antibody produced Pathogen eliminated May or may not Humoral immunity B cells Cellular immunity T cells Fin Fishes IMMUNE SYSTEM OF SHRIMP VS FISH
  • 56. DELIVERY METHODS Delivery method depends on various factors, including the fish species, size, specific disease & age Injection: Intra-peritoneal injection into the peritoneal cavity; Intramuscular injection into the muscle tissue used for larger fish species. Oral vaccines, it may be inactivated bacterial/viral cells or bacterial transformants with recombinants coated with feed pellets with oil & feed them Bio-encapsulation: Inactivated cells and recombinant bacterial transformants encapsulated with Artemia or rotifer and feeding to fish larvae
  • 57. Immersion bath: Fish immersed in a solution containing the vaccine for a specific period especially for smaller fish and stress-free Immersion vaccination: Fish/shrimp are coated with a vaccine suspension for a brief period, skin & gills absorb the vaccine Spray vaccines: Vaccine solution is sprayed onto the fish's skin or nostrils, helps to absorbing the vaccines, for skin & gills infection. Recombinant or transgenic microalgae with expressing viral and bacterial proteins are directly feeding to the fish and shrimp larvae.
  • 58. NANO DELIVERY Facilitate controlled release, target- based drug delivery, improve biocompatibility and biodegradability. Proteins, hydrophobic and hydrophilic biological macromolecules, peptides, DNA vaccines and other substances are all delivered via nanoparticles. This delivery improve adjuvant or antigen uptake by APCs, resulting greater immune responses. Peptides, cell lysates, DNA vaccines, and lipo-peptides have been conjugated with Poly (Lactic – co-Glycolic Acid) nanoparticles.
  • 59. Natural polymers: Created through physical and chemical processes, are extremely biocompatible for drug delivery. Chitosan, starch, alginate, cellulose, hyaluronic acid, chondroitin sulphate, and other extensively used natural polymer ingredients. Chitoson have several advantages like biodegradability, excellent biocompatibility, the ability to be functionalized, antibacterial capabilities, and natural processability. Tripolyphosphate (TPP), a cross-linking agent, has been added to the aqueous phase containing chitosan in a method for creating chitosan nanogels, absorbed into fish cells also useful to siRNA delivery
  • 60. CONCLUSIONS & FUTURE DIRECTIONS
  • 61. Utilizing the advanced biotechnological tools and expression system resulted efficient recombinant vaccine may produce and this will solve almost disease outbreaks. Advantages: Proper post translational modification and protein folding that gives strong and effective immunity Edible vaccine like IgY has been numerous benefits, including lower cost, greater convenience, and less invasiveness
  • 62. Transgenic micro algae has been expressing immunogenic proteins are highly valuable and effective against bacterial and viral pathogens especially to the Fish/shrimp young ones Nano-based delivery is powerful tools have so many advantages including controlled release of antigens and long lasting immunity